These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8191463)

  • 1. [Drug economics--a potent cure, but with the risk of adverse effects].
    Kristiansen IS
    Tidsskr Nor Laegeforen; 1994 Mar; 114(8):901-2. PubMed ID: 8191463
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceutical research: cost savings through innovation.
    Cohen KR; Levy RA
    AAPPO J; 1993 Oct; 3(5):28-36. PubMed ID: 10146463
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacoeconomics. Potent drugs, diseases are costly].
    Flaten O
    Tidsskr Nor Laegeforen; 1994 Apr; 114(11):1345-6. PubMed ID: 8079219
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving efficiencies in pharmaceutical distribution channels using the economic order quantity model.
    Sullivan DL; Schommer JC
    Clin Ther; 1993; 15(6):1146-53; discussion 1120. PubMed ID: 8111811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Economical evaluation of drugs. A steering method for the pharmaceutical sector of the 1990's?].
    Grund J; Husbyn H
    Tidsskr Nor Laegeforen; 1994 Mar; 114(8):947-50. PubMed ID: 8191475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical application of drugs with emphasis on more efficacy and lower costs].
    Xie H; Zhou H
    Zhonghua Yi Xue Za Zhi; 1995 Jan; 75(1):3-4. PubMed ID: 7600317
    [No Abstract]   [Full Text] [Related]  

  • 7. [New antidepressive agents--expenses and incomes].
    Hovind OB
    Tidsskr Nor Laegeforen; 1996 Apr; 116(11):1383. PubMed ID: 8658422
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacoeconomics. A new concept of an old practice].
    Palma-Aguirre JA
    Gac Med Mex; 1998; 134(5):621-4. PubMed ID: 9842147
    [No Abstract]   [Full Text] [Related]  

  • 9. Proposed drug-drug cost effectiveness methodology.
    Gagnon JP; Osterhaus JT
    Ann Pharmacother; 2006 Mar; 40(3):524-8. PubMed ID: 16507612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacoeconomics studies in specialized care: the principles, methods and practical applications].
    Soto Alvarez J
    An Med Interna; 1999 Jan; 16(1):41-6. PubMed ID: 10089651
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceuticals: drug importation--2005. End of Year Issue Brief.
    Varma P; Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708457
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacoeconomics.
    Sule NS; Nerurkar RP; Kamath SA
    J Assoc Physicians India; 2002 Aug; 50():1057-62. PubMed ID: 12421032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The power of pharmacoeconomics.
    Healthc Exec; 2000; 15(1):44-5. PubMed ID: 11067028
    [No Abstract]   [Full Text] [Related]  

  • 14. [Discount for only one drug of the same group leads to impaired health care quality].
    Bergström R
    Lakartidningen; 2006 Feb 8-14; 103(6):387-8; discussion 388. PubMed ID: 16536044
    [No Abstract]   [Full Text] [Related]  

  • 15. Where does high-quality research in economic evaluation come from?
    Zhang JX
    Pharmacotherapy; 2009 Jan; 29(1):1-2. PubMed ID: 19113791
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of a pharmaceutical risk sharing agreement based on the purchaser's total budget.
    Zaric GS; O'brien BJ
    Health Econ; 2005 Aug; 14(8):793-803. PubMed ID: 15685669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoeconomics in the era of individualized medicine.
    Waldman SA; Terzic A
    Clin Pharmacol Ther; 2008 Aug; 84(2):179-82. PubMed ID: 18679176
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacoeconomics.
    Ahuja J; Gupta M; Gupta AK; Kohli K
    Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THE ECONOMICS OF ADVERSE DRUG REACTIONS--case studies.
    Visconti JA; Smith MC
    Ann Pharmacother; 2006 Mar; 40(3):529-36. PubMed ID: 16507611
    [No Abstract]   [Full Text] [Related]  

  • 20. When will the U.S. flinch at cancer drug prices?
    Vanchieri C
    J Natl Cancer Inst; 2005 May; 97(9):624-6. PubMed ID: 15870428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.